Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Berne Stock Exchange  >  Wockhardt Bio AG    WBIO   CH0193042501

WOCKHARDT BIO AG

(WBIO)
  Report
Delayed Quote. Delayed Berne Stock Exchange - 11/06 12:00:00 pm
3.22 CHF   -4.45%
 SummaryQuotesChartsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Berne Stock Exchange
10/05/2020 10/06/2020 10/20/2020 10/23/2020 11/06/2020 Date
4.89(c) 0.52(c) 3.43(c) 3.37(c) 3.22(c) Last
5 800 500 700 60 300 Volume
+986.67% -89.37% +559.62% -1.75% -4.45% Change
More quotes
Financials (USD)
Sales 2019 337 M - -
Net income 2019 -23,5 M - -
Net Debt 2019 188 M - -
P/E ratio 2019 -1,11x
Yield 2019 -
Sales 2020 315 M - -
Net income 2020 24,6 M - -
Net Debt 2020 166 M - -
P/E ratio 2020 6,35x
Yield 2020 -
Capitalization 186 M 185 M -
EV / Sales 2019 0,64x
EV / Sales 2020 1,03x
Nbr of Employees -
Free-Float 99,0%
More Financials
Company
Wockhardt Bio AG is a Germany-based pharmaceutical company. It is active in the development, manufacturing and marketing of pharmaceutical and biopharmaceutical formulations. It offers a portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and forms. Its offering covers several therapeutic categories, such as central nervous system agents, hormones, cardiovascular agents,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about WOCKHARDT BIO AG

- No features available -

More news
News in other languages on WOCKHARDT BIO AG

- No features available -

More news
Chart WOCKHARDT BIO AG
Duration : Period :
Wockhardt Bio AG Technical Analysis Chart | WBIO | CH0193042501 | MarketScreener
Income Statement Evolution
Managers
NameTitle
Ajay Sahni Managing Director & Director
Ravindra Kamalakar Limaye Director